What’s Next for ID&V? Clinical Development Trends from ESCMID Global 2026
Explore several of the key themes emerging from ESCMID Global 2026.
Advancing Psychiatry Clinical Development Through Science, Precision, and Human-Centered DesignÂ
Mental health disorders affect an estimated one billion people worldwide, contributing to profound personal, social, and economic burden. As the World Health Organization notes, most…
Inside the Lab: Advancing Flow Cytometry in Clinical Trials – Q&A with Andre Olsson, PhD
I was interested in expanding my horizons beyond basic research and developing my knowledge in applied flow cytometry research. I...
Inside AD/PD 2026: Emerging Breakthroughs in Alzheimer’s and Parkinson’s
Authors: Carmen Gasca-Salas, MD, MSc, PhD, Medical Director, Medpace Recently, the Medpace neuroscience team attended the AD/PD (Alzheimer’s & Parkinson’s Disease)...
Expert Insights: How Targeted Protein Degraders are Advancing Oncology Drug Development with Dr. Blythe Thomson
As a Hematologist/Oncologist, I have always been a life-long advocate of the rigor and structure of a clinical trial. That...
Inside the Lab: Driving Global Clinical Trial Logistics – Q&A with George Andronos
I joined Medpace in 2006. I’ve had the privilege of experiencing Medpace’s labs from its early stages through its global...
Seamless Insights The Podcast: Clinical Research Associates
In this newly published episode of Seamless Insights: The Podcast, Hamish Baird, President of Remington Davis, sits down with Medpace...
Top 5 Breakthroughs in Stroke Research from ISC
Authors: James Vornov MD, PhD and Jessica Yehnert Recently, the Medpace stroke team attended ISC (International Stroke Conference). Among the many presentations, one study in...
World Obesity Day: The Evolution of Obesity Clinical Development
March 4th marks World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the...
Inside the Lab: Q&A with Santica Marcovina, Sr. Director of Clinical Laboratory Sciences
Santica Marcovina, PhD, ScD, FAHA, shares how advanced biomarker science is shaping today’s lipid-focused trials.